Floatz logo

Therapeutic Asset Ratings

200 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Progressive Brain Metastases
Massachusetts General HospitalP2CCC (53)
Pembrolizumab
Recurrent Brain Metastases
Massachusetts General HospitalP2CCC (53)
PREDNISONE TABLETS
Chemical Colitis
Massachusetts General HospitalP2CCC (53)
Ruxolitinib
Allogeneic Stem Cell Transplantation
Massachusetts General HospitalP2CCC (53)
Setmelanotide
Pseudohypoparathyroidism Type 1A
Massachusetts General HospitalP2CCC (53)
Siltuximab
Chronic Pain Syndrome
Massachusetts General HospitalP2CCC (53)
Siltuximab
Schwannoma
Massachusetts General HospitalP2CCC (53)
Siltuximab
Schwannomatosis
Massachusetts General HospitalP2CCC (53)
Tenofovir Alafenamide
Relapsing-Remitting Multiple Sclerosis
Massachusetts General HospitalP2CCC (53)
Trastuzumab Emtansine
PR-Positive Breast Cancer
Massachusetts General HospitalP2CCC (53)
Vinorelbine
Invasive Breast Cancer
Massachusetts General HospitalP2CCC (53)
[68ga]cbp8
Lung Cancer
Massachusetts General HospitalP2CCC (52)
Ritlecitinib
Celiac Disease
Massachusetts General HospitalP2CCC (52)
Tesamorelin
Abdominal Obesity
Massachusetts General HospitalP2CCC (52)
Tesamorelin
Frailty
Massachusetts General HospitalP2CCC (52)
Tesamorelin
Impaired Physical Function
Massachusetts General HospitalP2CCC (52)
2-(P-(2-(P-CHLOROBENZAMIDO)ETHYL)PHENOXY)-2-METHYLPROPIONIC ACID
Bipolar Disorder
Massachusetts General HospitalP2CCC (51)
[68ga]cbp8
Malignant Pancreatic Neoplasm
Massachusetts General HospitalP2CCC (51)
Dostarlimab
Triple-Negative Breast Carcinoma
Massachusetts General HospitalP2CCC (51)
Infliximab
Metastatic Melanoma
Massachusetts General HospitalP2CCC (51)
TACROLIMUS
Cognitive Disorder
Massachusetts General HospitalP2CCC (51)
7-ISOPROPOXYISOFLAVONE
Alzheimer Disease
Massachusetts General HospitalP2CCC (48)
Bimagrumab
Obesity Disorder
Massachusetts General HospitalP2CCC (48)
(±)-FTC
Multiple Sclerosis
Massachusetts General HospitalP2CCC (48)
Neratinib
Her2-Receptor Negative Breast Cancer
Massachusetts General HospitalP2CCC (48)
Showing 101 to 125 of 200 assets
PreviousPage 5 of 8Next